Mitosis or Veda: Which Fits Your DeFi Needs in 2026?

Mitosis is aimed at DeFi users and builders interested in shared liquidity across blockchain networks. Its design goal is to let users deposit once while applications access liquidity across chains; it also describes LP positions that can be tokenized and traded. That makes it the closer fit if you want to investigate cross-chain liquidity infrastructure or a tradable liquidity position.

Veda is infrastructure used by other businesses to offer onchain vaults and yield features. You generally encounter it through an exchange, wallet, neobank or protocol rather than by opening a standalone Veda account. So the practical product you assess is the partner’s vault, not an identical Veda-branded service available everywhere.

Neither chain list proves that every route, asset or strategy is live in every location. With Mitosis, verify the exact app and route. With Veda, identify the partner and the specific vault before you decide.

Neither project publishes a universal end-user fee schedule. Mitosis does not publish a schedule for deposits, position trades or withdrawals, so you need to check the exact action in the app and its current documentation. A transaction may also involve blockchain gas, and a strategy or route may have its own costs. Review the transaction preview and confirm what asset pays each charge before approving it.

Veda’s costs depend on the partner product, vault strategy and network. Check that product’s terms for management or performance fees, withdrawal charges, spreads and network costs. Also ask whether any displayed yield is before or after fees and whether it can change.

For either option, don’t treat a displayed rate or balance as your net outcome. If the fee breakdown or exit costs are unclear, pause rather than committing funds based on an estimate.

Neither is established as the safer choice by the audit count alone: both list two audits, but the reports, scope and findings are not identified in the details given here. An audit is not a guarantee against vulnerabilities, losses or operational problems. For Veda, the specific partner, vault contracts, strategy and connected protocols all matter. For Mitosis, check the contracts and the cross-chain route involved in your transaction.

Mitosis describes its infrastructure as non-custodial and says applications cannot directly access user funds. Treat that as a project claim to verify against the contracts and permissions you would use. Veda’s partner-based model adds another party whose controls and terms you should review.

Before depositing, look for current, scope-specific security information for the exact product. Confirm how withdrawals work and what happens if a route, strategy or partner has a problem. If those details are missing, that uncertainty should weigh in your decision.

Veda may be easier to approach if you already use a partner that offers a Veda-powered vault: you can assess the feature inside that product. But there is no single Veda user interface or shared set of deposit and withdrawal rules. The partner determines which assets, networks, vaults and controls are available, so check its terms and security disclosures rather than assuming they apply across Veda.

Mitosis offers an app and documentation, but its broad chain list is not a catalogue of confirmed live assets or routes. Before connecting, match the app’s network to your wallet and the asset you intend to use. Verify how you can withdraw, including any additional transactions, and keep enough of the relevant asset for network fees.

For either service, start only after you understand the deposit and exit steps. A small initial amount can limit exposure, but it does not remove contract, strategy or route risk.

Choose Veda if your goal is to evaluate an onchain vault offered by a product you already use, or if you’re building a product that needs vault infrastructure. Veda’s role is to support partner offerings; it does not give you one standard consumer vault with universal terms. Your decision should turn on the specific partner’s strategy, fees, withdrawal rules and security disclosures.

Choose Mitosis if you’re researching shared cross-chain liquidity or the possibility of trading tokenized LP positions. Its appeal is the cross-chain design, but you should confirm that the exact app, asset and withdrawal route you need are available. Mitosis does not publish a fee schedule, and its two listed audits do not identify scope or reports.

If predictable fees and clearly documented exits are essential, don’t deposit with either until you can verify those details for the specific product. The right choice depends more on the use case and actual route than on the number of chains listed.